Home > Healthcare > Medical Devices > Diagnostic Devices > HLA Typing for Transplant Market
HLA Typing for Transplant Market size was worth more than USD 735 million in 2022 and is projected to expand at over 8.5% CAGR from 2023-2032.
Increasing frequency of solid organ transplant procedures will have a positive impact on the HLA typing for transplant industry dynamics. HLA typing or human leukocyte antigen typing is used to match donors and recipients during bone marrow or cord blood transplants. Rising incidences of diseases necessitating bone marrow transplants such as lymphomas, multiple myeloma, leukemia, and immune deficiency disorders, will propel the need for HLA typing.
A shortage of donors could restrain the market expansion. The presence of a substantial gap between the number of organs required and the organs donated is a major challenge for the healthcare community. Despite advances in medical technology and rigorous campaigns promoting the need for organ donors, there exists a considerable disparity between supply and demand.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
HLA Typing for Transplant Market Size in 2022: | USD 735 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.5% |
2032 Value Projection: | USD 1.7 Billion |
Historical Data for: | 2018 to 2032 |
No. of Pages: | 255 |
Tables, Charts & Figures: | 372 |
Segments covered: | Technology, Product & Services, Application, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|